NORUCHOLIC ACID THERAPY DURING NORMOTHERMIC MACHINE PERFUSION IMPROVES GRAFT VIABILITY AND BILIARY MARKERS IN LIVERS UNSUITABLE FOR TRANSPLANTATION

Jule Dingfelder:Department of General Surgery, Division of Transplantation,Medical University of Vienna,Vienna,Austria;Department of General Surgery, Division of Visceral Surgery,Medical University of Vienna,Vienna,Austria|Laurin Rauter:Department of General Surgery, Division of Transplantation,Medical University of Vienna,Vienna,Austria|Dagmar Kollmann:Department of General Surgery, Division of Visceral Surgery,Medical University of Vienna,Vienna,Austria|Moriz Riha:Department of General Surgery, Division of Transplantation,Medical University of Vienna,Vienna,Austria;Department of General Surgery, Division of Visceral Surgery,Medical University of Vienna,Vienna,Austria|Nikolaus Becker:Department of General Surgery, Division of Transplantation,Medical University of Vienna,Vienna,Austria|Sertac Kacar:Department of General Surgery, Division of Transplantation,Medical University of Vienna,Vienna,Austria;Department of Urology and Transplantation,Klinikum Stuttgart,Stuttgart,Germany|Claudia Fuchs:Department of Internal Medicine III, Division of Gastroenterology and Hepatology,Medical University of Vienna,Vienna,Austria|Lovro Davidovski:Institute of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology,Medical University of Vienna,Vienna,Austria|Celine Nemethy:Institute of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology,Medical University of Vienna,Vienna,Austria|Raphael Gronauer:Institute of Bioinformatics, Biocenter Innsbruck,Medical University of Innsbruck,Innsbruck,Austria|Friedrich Jakse:Clinical Institute of Pathology,Medical University of Vienna,Vienna,Austria|Katharina Wöran:Clinical Institute of Pathology,Medical University of Vienna,Vienna,Austria|Hubert Hackl:Institute of Bioinformatics, Biocenter Innsbruck,Medical University of Innsbruck,Innsbruck,Austria|Matthias Hackl:TAmiRNA GmbH,Vienna,Austria|Emina Halilbasic:Department of Internal Medicine III, Division of Gastroenterology and Hepatology,Medical University of Vienna,Vienna,Austria|Patrick Starlinger:Department of Surgery, Division of Hepatobiliary and Pancreas Surgery,Mayo Clinic Rochester,Rochester, Minnesota,United States|Alice Assinger:Institute of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology,Medical University of Vienna,Vienna,Austria|Gabriela Berlakovich:Department of General Surgery, Division of Transplantation,Medical University of Vienna,Vienna,Austria|Michael Trauner:Department of Internal Medicine III, Division of Gastroenterology and Hepatology,Medical University of Vienna,Vienna,Austria|David Pereyra:Department of General Surgery, Division of Transplantation,Medical University of Vienna,Vienna,Austria;Department of General Surgery, Division of Visceral Surgery,Medical University of Vienna,Vienna,Austria;Department of Surgery, Division of Hepatobiliary and Pancreas Surgery,Mayo Clinic Rochester,Rochester, Minnesota,United States|Georg Györi:Department of General Surgery, Division of Transplantation,Medical University of Vienna,Vienna,Austria

EVALUATION OF ANTI-ENTEROCOCCUS AGENTS FOR PERI-OPERATIVE ANTIBIOTIC PROPHYLAXIS ON THE BILIARY COMPLICATIONS AFTER LIVER TRANSPLANTATION.

Isaure Breteau:CHU de Tours,Tours,France;INSERM-ISCHEMIA,Tours,France|Petru Bucur:CHU de Tours,Tours,France;INSERM-ISCHEMIA,Tours,France|Raphaël Denhaut:CHU de Tours,Tours,France|Ephrem Salamé:CHU de Tours,Tours,France;INSERM-ISCHEMIA,Tours,France|Eric Lesvesque:CHU de Tours,Tours,France

LIVER INJURY ANALYSIS USING SPATIAL PROTEOMICS

Lanette Marie Christensen:University of Pennsylvania,Philadelphia,United States|Arianna Barbetta:University of Southern California,Los Angeles,United States|Zhonglin Wang:University of Pennsylvania,Philadelphia,United States|Rongxiang Han:Children's Hospital of Philadelphia,Philadelphia,United States|Guanghui Ge:University of Pennsylvania,Philadelphia,United States|Wayne Hancock:University of Pennsylvania,Philadelphia,United States;Children's Hospital of Philadelphia,Philadelphia,United States|Juliet Emamaullee:University of Southern California,Los Angeles,United States|Matthew Levine:University of Pennsylvania,Philadelphia,United States;Children's Hospital of Philadelphia,Philadelphia,United States

NOVEL USE OF CANGRELOR, AN INTRAVENOUS ANTIPLATELET IN LIVER TRANSPLANTATION

Dalia Bashir:Pediatrics,Texas Childrens Hospital,Houston,United States|Moreshwar Desai:Texas Childrens Hospital,Houston,United States|Anna Banc-husu:Pediatrics,Texas Childrens Hospital,Houston,United States|Marielle Faraone:Surgery,Texas Childrens Hospital,Houston,United States|Kelby Fuller:Texas Childrens Hospital,Houston,United States|Dana Cerminara:Texas Childrens Hospital,Houston,United States|Howard Pryor:Surgery,Texas Childrens Hospital,Houston,United States|Lisa Hensch:Pathology,Texas Childrens Hospital,houston,United States|Jun Teruya:Pathology,Texas Childrens Hospital,Houston,United States|John Goss:Surgery,Baylor College Of Medicine,Houston,United States|Kevin Huang:Surgery,Baylor College Of Medicine,Houston,United States|Nhu Thao Nguyen Galvan:Surgery,Baylor College Of Medicine,Houston,United States

EVOLUTION OF PATIENT SELECTION FOR HCC IN LIVER TRANSPLANTATION
: IMPROVED ONCOLOGIC OUTCOMES FOLLOWING ADOPTION OF MILAN+1 CRITERIA IN A SMALL-VOLUME CENTER

Jaehun Yang:Surgery,Gachon University Gil Medical Center,Incheon,Korea, Republic Of|Yeon Ho Park:Surgery,Gachon University Gil Medical Center,Incheon,Korea, Republic Of|Doojin Kim:Surgery,Gachon University Gil Medical Center,Incheon,Korea, Republic Of|Sang-Tae Choi:Surgery,Gachon University Gil Medical Center,Incheon,Korea, Republic Of|Doo-Ho Lee:Surgery,Gachon University Gil Medical Center,Incheon,Korea, Republic Of

ARTERIAL COMPLICATIONS IN LIVING DONOR LIVER TRANSPLANTATION

Kakhaber Kashibadze:Liver Disease and Transplant Department,Batumi University Hospital,Batumi,Georgia;Department of Surgery,Batumi Shota Rustaveli State University,Batumi,Georgia;Department of Surgery,Avicenna Batumi Medical University,Batumi,Georgia|Merab Nakashidze:Liver Disease and Transplant Department,Batumi University Hospital,Batumi,Georgia;Department of Surgery,Batumi Shota Rustaveli State University,Batumi,Georgia|Davit Beridze:Liver Disease and Transplant Department,Batumi University Hospital,Batumi,Georgia;Department of Surgery,Batumi Shota Rustaveli State University,Batumi,Georgia|Ruslan Bolkvadze:Liver Disease and Transplant Department,Batumi University Hospital,Batumi,Georgia;Department of Surgery,Batumi Shota Rustaveli State University,Batumi,Georgia|Tamar Mikeladze:Department of Radiology,Batumi University Hospital,Batumi,Georgia|Lasha Mikeladze:Liver Disease and Transplant Department,Batumi University Hospital,Batumi,Georgia;Department of Surgery,Batumi Shota Rustaveli State University,Batumi,Georgia;Department of Surgery,Avicenna Batumi Medical University,Batumi,Georgia

UNCONTROLLABLE BLEEDING - MOST UNDESIRABLE COMPLICATION OF LIVING DONOR LIVER TRANSPLANTATION

Kakhaber Kashibadze:Liver Disease and Transplant Department,Batumi University Hospital,Batumi,Georgia;Department of Surgery,Batumi Shota Rustaveli State University,Batumi,Georgia;Deparment of Surgery,Avicenna Batumi Medical University,Batumi,Georgia|Teimuraz Peshkov:Liver Disease and Transplant Department,Batumi University Hospital,Batumi,Georgia|Sophio Beridze:Department of Internal Medicine,Batumi Shota Rustaveli State University,Batumi,Georgia|Meri Beridze:Liver Disease and Transplant Department,Batumi University Hospital,Batumi,Georgia|Nia Gogitidze:Liver Disease and Transplant Department,Batumi University Hospital,Batumi,Georgia;Department of Anesthesia and Critical Care,Avicenna Batumi Medical University,Batumi,Georgia|Marika Mortuladze:Batumi Shota Rustaveli State University,Batumi,Georgia|Lasha Mikeladze:Liver Disease and Transplant Department,Batumi University Hospital,Batumi,Georgia;Department of Surgery,Batumi Shota Rustaveli State University,Batumi,Georgia;Deparment of Surgery,Avicenna Batumi Medical University,Batumi,Georgia

IMPROVED EARLY OUTCOMES IN HIGH-RISK LIVER TRANSPLANT RECIPIENTS IN THE MODERN ERA

Lauren Matevish:Department of Surgery,UT Southwestern Medical Center,Dallas,United States

INACCURACY OF SERIAL LACTATE MEASUREMENTS IN PREDICTING GRAFT FUNCTION AFTER LIVING DONOR

LIVER TRANSPLANTATION: A PROSPECTIVE OBSERVATIONAL STUDY

Elavarasan R:Liver anaesthesia and critical care,Rela Institute and Medical Center,chennai,India|Balaji Balasubramanian:Liver anaesthesia and critical care,Rela Institute and Medical Center,chennai,India|Amal Francis Sam:Liver anaesthesia and critical care,Rela Institute and Medical Center,chennai,India|Susan Paulin:Liver anaesthesia and critical care,Rela Institute and Medical Center,chennai,India|Akila Rajakumar:Liver anaesthesia and critical care,Rela Institute and Medical Center,chennai,India|Ashwin Rammohan:liver transplant and hepatopancreaticobiliary surgery,Rela Institute and Medical Center,chennai,India|Mohamed Rela:liver transplant and hepatopancreaticobiliary surgery,Rela Institute and Medical Center,chennai,India

AWARENESS AND ATTITUDE ABOUT ORGAN DONATION AMONG EGYPTIAN PHYSICIANS

Maha Mohsen Hussein:Internal Medicine Department,Ain Shams University,Cairo,Egypt|Iman Fawzy Montasser:Tropical Medicine Department,Ain Shams University,Cairo,Egypt|Manar Mohamed Ellaban:Community Department,Ain Shams University,Cairo,Egypt|Mahmoud El Meteini:Hepatobiliary Surgery &Liver Transplantation,Ain Shams University,Cairo,Egypt